全球數位基因組學市場按產品、應用、最終用戶和地區分類

2025 年全球數位基因體學市場價值預估為 353.5 億美元，預計到 2032 年將達到 847.8 億美元，2025 年至 2032 年的複合年成長率為 13.3%。

數字。 2025 年數位基因體學市場佔有率（%），依地區分類

受基因序列測定和資料分析成本下降的推動，全球數位基因組學市場預計將在未來十年大幅成長。高通量 DNA 定序技術的進步使研究人員能夠以前所未有的速度和經濟性對整個人類基因組進行定序。這加速了遺傳疾病研究、藥物研發、精準醫療和診斷等多個領域的研究。一些公司正在開發結合次世代定序儀定序平台、先進的生物資訊學工具和臨床決策支援系統的整合解決方案。該技術有望透過基於個人獨特基因特徵的早期疾病檢測和標靶治療方法來改變醫療保健領域。

市場動態：

由於多種因素，全球數位基因組學市場正在經歷強勁成長。 DNA測序技術成本的下降，以及提供更高通量、更長讀取距離的第三代定序平台的出現，正在降低基因測序的成本。這使得基因組分析更適用於臨床應用。政府和私人組織對基因組研究的資助增加也刺激了數位基因組解決方案的採用。然而，圍繞共用基因組資料的監管和道德問題帶來了挑戰。缺乏熟練人力和處理大型基因組資料集的技術挑戰也限制了市場的發展。整合基因組資料的臨床決策支援系統的開發代表著一個巨大的商機。用於儲存、分析和管理基因組資料的雲端基礎的平台有可能加速精準醫療方法的發展。

本研究的主要特點

本報告對全球數位基因組市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。

它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球數位基因組學市場的主要企業是根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行的分析。

主要公司包括 Illumina、Thermo Fisher Scientific、Qiagen、Agilent Technologies 和 F. Hoffmann-La Roche。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球數位基因組市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球數位基因組學市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第 4 章全球數位基因體學市場：COVID-19 疫情的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

第 5 章。全球數位基因組學市場按產品分類（2020-2032 年）

• 定序和分析儀器
• DNA/RNA 分析套件
• 定序晶片
• 定序和分析軟體
• 樣品製備設備

6. 全球數位基因體學市場按應用分類（2020-2032 年）

• 臨床
• 生殖健康
• 腫瘤學
• 心血管疾病
• 神經系統疾病
• 法醫學
• 藥物研發
• 其他

7. 全球數位基因組學市場（按最終用戶分類） (2020-2032)

• 醫院
• 診斷中心和法醫學實驗室
• 研究所
• 其他

8. 全球數位基因體學市場按地區分類（2020-2032 年）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • GenomeMe Inc.
  • NanoString Technologies, Inc.
  • Agilent Technologies
  • Becton Dickinson（BD）
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics.

第 10 章分析師建議

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map（COM）

第 11 章調查方法

• 參考
• 調查方法

Global Digital Genome Market is estimated to be valued at USD 35.35 Bn in 2025 and is expected to reach USD 84.78 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Figure. Digital Genome Market Share (%), By Region 2025

The global digital genome market is set to grow substantially over the next decade driven by declining costs of genomic sequencing and data analysis. Advancements in technologies for high-throughput DNA sequencing are enabling researchers to sequence entire human genomes at an unprecedented speed and affordable costs. This has accelerated research in various domains including genetic disease research, drug discovery, precision medicine, and diagnostics. Several companies are developing integrated solutions combining next-generation sequencing platforms, advanced bioinformatics tools, and clinical decision support systems. This is expected to transform the healthcare sector by enabling early disease detection and targeted treatment approaches based on an individual's unique genetic profile.

Market Dynamics:

The global digital genome market is witnessing strong growth driven by several factors. Declining costs of DNA sequencing technologies and emergence of third generation sequencing platforms that provide longer reads at higher throughput are reducing the costs of genome sequencing. This is making genomic analysis accessible for clinical applications. Growing funding for genomic research from government and private organizations is also fueling the adoption of digital genome solutions. However, regulatory and ethical issues related to genomic data sharing present a challenge. Lack of skilled workforce and technical challenges in handling huge genomic datasets pose restraints on the market. Development of clinical decision support systems integrated with genomic data presents a major opportunity. Cloud-based platforms for the storage, analysis, and management of genomic data could accelerate precision medicine approaches.

Key Features of the Study:

This report provides in-depth analysis of the global digital genome market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global digital genome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, F. Hoffmann-La Roche

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global digital genome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital genome market

Detailed Segmentation-

• By Product
  • Sequencing and Analyzer Instruments
  • DNA/RNA Analysis Kits
  • Sequencing Chips
  • Sequencing and Analysis Software
  • Sample Preparation Instruments
• By Application
  • Clinical
  • Reproductive Health
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others
  • Forensics
  • Drug Discovery and Development
  • Others
• By End User
  • Hospitals
  • Diagnostic Centers and Forensic Labs
  • Research Institutes
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • GenomeMe Inc.
  • NanoString Technologies, Inc.
  • Agilent Technologies
  • Becton Dickinson (BD)
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Digital Genome Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Digital Genome Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Sequencing and Analyzer Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• DNA/RNA Analysis Kits
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sequencing Chips
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sequencing and Analysis Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sample Preparation Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Digital Genome Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reproductive Health
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Others
• Forensics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Discovery and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Digital Genome Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers and Forensic Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Digital Genome Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QIAGEN
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GenomeMe Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NanoString Technologies, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies
  • Becton Dickinson (BD)
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Research Methodology

• References
• Research Methodology
• About us and Sales Contact